Fulgent Genetics (FLGT) vs Kewaunee Scientific (KEQU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Fulgent Genetics (FLGT) has outperformed Kewaunee Scientific (KEQU) over the past year, losing 8.8% versus a loss of 22.8%. Over five years, KEQU leads with a +156.2% price change compared with -73.3% for FLGT. Fulgent Genetics is the larger company by market cap ($572.9 million vs $97.9 million), about 5.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLGT | KEQU |
|---|---|---|
| Share price | $20.82 | $33.82 |
| Market cap | $572.87M | $97.92M |
| 1-day change | +1.22% | -0.06% |
| YTD return | -20.75% | -9.60% |
| 1-year return | -8.80% | -22.84% |
| 5-year return | -73.31% | +156.21% |
| P/E ratio (TTM) | — | 12.25 |
| Forward P/E | — | 15.66 |
| EPS (TTM) | $-2.82 | $2.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.04 | $46.57 |
| 52-week low | $13.46 | $32.00 |
| Distance from 52-week high | -32.93% | -27.38% |
| Analyst consensus | none | — |
| Avg. price target upside | -8.74% | — |
| Average volume | 301.04K | 4.22K |
| Shares outstanding | 27.52M | 2.90M |
| Employees | 1,315 | 1,231 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fulgent Genetics is about 5.9 times larger than Kewaunee Scientific by market value ($572.87M vs $97.92M).
- FLGT has outperformed KEQU by 14.0 percentage points over the past year.
- The two companies sit in different sectors: Fulgent Genetics in Health Care and Kewaunee Scientific in Industrials.
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Health Care · Medical Specialities · 1,315 employees
About Kewaunee Scientific
KEQU stock →Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International.
Industrials · Medical Specialities · 1,231 employees
FLGT vs KEQU FAQ
Which is bigger, Fulgent Genetics or Kewaunee Scientific?
Fulgent Genetics (FLGT) is larger, with a market capitalization of $572.87M compared with $97.92M for Kewaunee Scientific (KEQU).
Which stock has performed better over the past year, FLGT or KEQU?
FLGT returned -8.80% over the past 12 months, compared with -22.84% for KEQU (price return, excluding dividends). Past performance does not predict future results.
Are Fulgent Genetics and Kewaunee Scientific in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.